Mitch C. Hill
CIK 1644989 · Chief Financial Officer · last filed 2026-06-03
Mitch C. Hill is a Chief Financial Officer who has filed 84 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for CVRX, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$25.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NARI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SOUTHLAKE, TX 76902
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVRX | Director | 8,720 | $1.42 | $12.4K | $0 | 3 | 2026-06-03 |
| Inari Medical, Inc. (NARI) Delisted | Chief Financial Officer | 179,133 | $79.97 | $14.33M | -$25.83M | 66 | 2024-10-02 |
Recent Filings
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | CVRX | Grant (A) | +8,720 | $0 | EDGAR |
| 2025-06-05 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2024-12-12 | — | Notice (144) | −3,000 | -$174.6K | EDGAR |
| 2024-10-02 | Inari Medical, Inc. (NARI) Delisted | Tax (F) | −2,067 | -$84.0K | EDGAR |
| 2024-09-13 | Inari Medical, Inc. (NARI) Delisted | Mixed | — | -$134.0K | EDGAR |
| 2024-09-12 | — | Notice (144) | −12,000 | -$540.8K | EDGAR |
| 2024-09-05 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | Inari Medical, Inc. (NARI) Delisted | Mixed | — | -$237.7K | EDGAR |
| 2024-07-16 | Inari Medical, Inc. (NARI) Delisted | Mixed | — | -$267.5K | EDGAR |
| 2024-07-03 | Inari Medical, Inc. (NARI) Delisted | Tax (F) | −2,067 | -$103.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.